EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Factors Associated With Concurrent Benzodiazepine and Opioid Use Following Total Hip and Knee Arthroplasty: A Nationwide Cohort Study

Manuela Yepes-Calderón, Rob G H H Nelissen, Marcel L Bouvy, Liza N van Steenbergen, Albert Dahan, Frits R Rosendaal, Maaike G J Gademan

Pharmacoepidemiology and Drug Safety · 2026

DOI: 10.1002/pds.70368 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2026. Verfasst von Manuela Yepes-Calderón und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Benzodiazepines, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Analgesics, Opioid. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dutch Arthroplasty Register (LROI),.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Concurrent use of benzodiazepines and opioids is discouraged due to synergistic adverse effects. However, patients undergoing total hip or knee arthroplasty (THA/TKA) often receive them, particularly in the first 3 postoperative months. We identified factors associated with new outpatient concurrent benzodiazepine‐opioid dispensation following THA/TKA.

Methods

In this nationwide cohort study, we linked the Dutch Arthroplasty Register with the Dutch Foundation for Pharmaceutical Statistics, which provided medication dispensation data. We included all patients undergoing primary elective THA/TKA (2013–2022) who had no preoperative concurrent use in the 6 months pre‐procedure. The primary outcome was ≥ 7 days of a new concurrent benzodiazepine‐opioid dispensation within 90‐day postoperative. Determinants included patient and implant characteristics, and preoperative medication use. Multivariable logistic regression analyses were performed, adjusted for age, sex, and comorbidity.

Results

Among 89 139 THA and 76 710 TKA patients, 3756 (4%) and 5571 (7%), respectively, received new postoperative concurrent benzodiazepine‐opioid dispensation within 90‐days postoperative. The main factor associated with such dispensation was preoperative benzodiazepine use (THA: OR 23.5 [95% CI: 21.8–25.3], TKA: OR 22.8 [95% CI: 21.3–24.3]), followed by preoperative antidepressant/anxiolytic use (THA: OR 2.9 [95% CI: 2.6–3.1], TKA: OR 2.5 [95% CI: 2.3–2.7]). Other factors included female sex, current smoking, and American Society of Anesthesiologists (ASA) scale III‐IV. Preoperative pain scores, preoperative opioid use, and implant characteristics showed little to no association with the outcome.

Conclusions

Preoperative benzodiazepine use was the main factor associated with new outpatient concurrent benzodiazepine‐opioid dispensation after THA/TKA, followed by preoperative antidepressant/anxiolytic use. These results highlighted that careful review of the patient's medication history when planning postoperative pain management could help prevent unsafe co‐prescription.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesArthroplasty, Replacement, HipArthroplasty, Replacement, KneeAnalgesics, OpioidPostoperative PainHumansFemaleMaleAgedCohort StudiesNetherlandsMiddle AgedRegistriesAged, 80 and over

Stichwörter der Autor:innen

arthroplastybenzodiazepinesconcurrent useopioidspharmacoepidemiologypolypharmacy

Substanzen

BenzodiazepinesAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Orthopedics, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Dutch Arthroplasty Register (LROI), 's-Hertogenbosch, the Netherlands.
  • Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands.
  • Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands.

Förderung

  • Dutch Arthroplasty Register (LROI),

Zitieren

APA

Yepes-Calderón, M., Nelissen, R. G. H. H., Bouvy, M. L., van Steenbergen, L. N., Dahan, A., Rosendaal, F. R., & Gademan, M. G. J. (2026). Factors Associated With Concurrent Benzodiazepine and Opioid Use Following Total Hip and Knee Arthroplasty: A Nationwide Cohort Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70368

Vancouver

Yepes-Calderón M, Nelissen RGHH, Bouvy ML, van Steenbergen LN, Dahan A, Rosendaal FR, et al. Factors Associated With Concurrent Benzodiazepine and Opioid Use Following Total Hip and Knee Arthroplasty: A Nationwide Cohort Study. Pharmacoepidemiology and Drug Safety. 2026. doi:10.1002/pds.70368

BibTeX
@article{YepesCaldern2026,
  author = {Yepes-Calderón, Manuela and Nelissen, Rob G H H and Bouvy, Marcel L and van Steenbergen, Liza N and Dahan, Albert and Rosendaal, Frits R and Gademan, Maaike G J},
  title = {Factors Associated With Concurrent Benzodiazepine and Opioid Use Following Total Hip and Knee Arthroplasty: A Nationwide Cohort Study},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  doi = {10.1002/pds.70368}
}
Kostenlos starten →